US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 44.560
  • -0.370-0.82%
Close Sep 27 16:00 ET
  • 44.560
  • 0.0000.00%
Post 20:02 ET
2.62BMarket Cap16.38P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protagonist Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 33.363M--
--2024/Q3-- / 1.875M--
--2024/Q24.167M / 6.667M--
--2024/Q1254.953M / 120.000M--
--2023/Q460.000M / 30.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 33.363M--
--2024/Q3-- / 1.875M--
--2024/Q24.167M / 6.667M--
--2024/Q1254.953M / 120.000M--
--2023/Q460.000M / 30.000M--

Unlock Free Earnings Estimates

Protagonist Therapeutics Earnings Reports

  • Protagonist Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:24 ET

  • Protagonist Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 16:59 ET

  • Protagonist Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 22:39 ET

  • Protagonist Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 17:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 24, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data